Tell your MP to defend access to medicines in the UK-India deal

3,083 people have already emailed their MP

Will you help reach 4,000?

Your details

Your message

First name *

Last name *

E-mail address *

Address line 1 *

Address line 2

Postcode *

Phone number

If you provide your phone number we may call or text you to tell you more about our campaigns and how you can help, including supporting our work with a donation.

Keep me updated via email*

I am happy to receive emails about campaign updates, ways to get involved and how to support Global Justice Now's work with a donation. (You can unsubscribe at any time).

Email subscription *

Yes

Without your consent we won’t be able to send you updates on the progress of our campaigns, urgent actions, local events, surveys to have your say, and other ways to be part of the movement for global justice.

Please don't send me information by post (More info)

Don’t add me to your postal mailings list

If you tick this box we won’t be able to send you information through the post about how you can support our campaigns, and you won’t be able to receive our magazine if you are a member. If you currently don’t receive post but would like to, please email supporterservices@globaljustice.org.uk or call us on 020 7820 4900. Due to long lead-in times, changes can sometimes take up to a month to take effect.

Read our privacy policy here

Leave this field blank

Trade agreement MP action.png

A leaked draft chapter of the UK-India trade negotiations shows that the British government is pressuring India to adopt rules that would drive up medicines prices.

If agreed, the UK’s demands would threaten the NHS and have a devastating impact on public health across the world.

We need to stop this. Ask your MP to help stop these proposals.

The government’s apparent plan is to push through stricter intellectual property (IP) rules on India that would shore up big pharma’s medicine monopolies and drive up the price of cheap generic medicines produced in India. This won’t just harm the global south – a quarter of all medicines used in the NHS come from India’s successful generics industry.

No recent activity.